The preparation and properties of monometallic and bimetallic complexes of rhenium(I) tricarbonyl chloride coordinated to 4,4'-dimethyl-2,2'-bipyridine ((CH3)2bpy), 2,2'-bipyrimidine (bpm), 2,3-bis(2-pyridyl)pyrazine (bpp), and l,2-bis(4'-methyl-2,2'-bipyridyl-4-yl)ethane (Mebpy-Mebpy) are described. The CO stretching frequencies were in accord with facial geometry for the complexes. The NMR properties revealed that protons on the carbon atoms a to the coordinating nitrogen atoms of coordinated heterocycles were deshielded and shifted downfield. Electrochemically, one or two irreversible oxidations, a reversible reduction assignable to reduction of the heterocyclic ligand, and a second reduction (irreversible) at a potential more negative than that of the first were observed. The monometallic complexes displayed dir -* ir* transitions in the 360-380-nm region. The transition red-shifted to 454 nm for [(bpp)(Re(CO)3Cl)2] and to 480 nm for [(bpm)(Re(CO)3Cl)2] but remained at 366 nm for [(Mebpy-Mebpy)(Re(CO)3Cl)2], Emission was observed at room temperature for [((CH3)2bpy)Re(CO)3Cl], [(Mebpy-Mebpy)Re(CO)3Cl], [(bpp)Re(CO)3Cl], and [(Mebpy-Mebpy)(Re(CO)3Cl)2], Their emission maxima were located near 600 nm except for [(bpp)Re(CO)3Cl]. Its emission maximum was observed at 700 nm.84ER-13263 and the National Science Foundation under Grant CHE-8719709 for support. Supplementary Material Available: A listing of decoupling parameters, results, and conclusions for NMR experiments with [(Mebpy-Mebpy)-Re(CO)3Cl], [(bpp)Re(CO)3Cl], and [(bpp)(Re(CO)3Cl)2] (4 pages). Ordering information is given on any current masthead page.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.